Literature DB >> 25017080

Expanded criteria donors.

Sandy Feng1, Jennifer C Lai2.   

Abstract

The greatest challenge facing liver transplantation today is the shortage of donor livers. Demand far exceeds supply, and this deficit has driven expansion of what is considered an acceptable organ. The evolving standard has not come without costs, however, as each new frontier of expanded donor quality (i.e., advancing donor age, donation after cardiac death, and split liver) may have traded wait-list for post-transplant morbidity and mortality. This article delineates the nature and severity of risk associated with specific deceased donor liver characteristics and recommends strategies to maximally mitigate these risks.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Deceased donor; Donor age; Outcomes; Steatosis; Surgery

Mesh:

Year:  2014        PMID: 25017080      PMCID: PMC4809362          DOI: 10.1016/j.cld.2014.05.005

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  116 in total

Review 1.  Non-alcoholic steatohepatitis: definitions and pathogenesis.

Authors:  C P Day; S Saksena
Journal:  J Gastroenterol Hepatol       Date:  2002-12       Impact factor: 4.029

Review 2.  AGA technical review on nonalcoholic fatty liver disease.

Authors:  Arun J Sanyal
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

3.  Tumors and transplantation: The 2003 Third Annual ASTS State-of-the-Art Winter Symposium.

Authors:  Sandy Feng; Joseph F Buell; Ravi S Chari; J Michael DiMaio; Douglas W Hanto
Journal:  Am J Transplant       Date:  2003-12       Impact factor: 8.086

4.  Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection.

Authors:  Robin Biswas; Edward Tabor; Chu Chieh Hsia; David J Wright; Megan E Laycock; Eberhard W Fiebig; Lorraine Peddada; Richard Smith; George B Schreiber; Jay S Epstein; George J Nemo; Michael P Busch
Journal:  Transfusion       Date:  2003-06       Impact factor: 3.157

5.  Prevention of de novo hepatitis B virus infection in living donor liver transplantation using hepatitis B core antibody positive donors.

Authors:  Yaw-Sen Chen; Chih-Chi Wang; Vanessa H de Villa; Shih-Hor Wang; Yu-Fan Cheng; Tung-Liang Huang; Bruno Jawan; King-Wah Chiu; Chao-Long Chen
Journal:  Clin Transplant       Date:  2002-12       Impact factor: 2.863

6.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

7.  Use of liver grafts from donors positive for antihepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis-B immunoglobulin and lamivudine.

Authors:  Jose R Nery; Caio Nery-Avila; K Rajender Reddy; Robert Cirocco; Deborah Weppler; David M Levi; Seigo Nishida; Juan Madariaga; Tomoaki Kato; Phillip Ruiz; Eugene Schiff; Andreas G Tzakis
Journal:  Transplantation       Date:  2003-04-27       Impact factor: 4.939

8.  Risk factors for and clinical course of non-anastomotic biliary strictures after liver transplantation.

Authors:  Maureen M J Guichelaar; Joanne T Benson; Michael Malinchoc; Ruud A F Krom; Russell H Wiesner; Michael R Charlton
Journal:  Am J Transplant       Date:  2003-07       Impact factor: 8.086

9.  Long-term survival of recipients of liver grafts from donors older than 80 years: is it achievable?

Authors:  Matteo Cescon; Gian Luca Grazi; Giorgio Ercolani; Bruno Nardo; Matteo Ravaioli; Andrea Gardini; Antonino Cavallari
Journal:  Liver Transpl       Date:  2003-11       Impact factor: 5.799

10.  Pretransplant model to predict posttransplant survival in liver transplant patients.

Authors:  Rafik M Ghobrial; Jeffery Gornbein; Randy Steadman; Natale Danino; James F Markmann; Curtis Holt; Dean Anselmo; Farin Amersi; Pauline Chen; Douglas G Farmer; Steve Han; Francisco Derazo; Sammy Saab; Leonard I Goldstein; Sue V McDiarmid; Ronald W Busuttil
Journal:  Ann Surg       Date:  2002-09       Impact factor: 12.969

View more
  20 in total

Review 1.  Use of Hepatitis C-Positive Liver Grafts in Hepatitis C-Negative Recipients.

Authors:  Akshay Shetty; Adam Buch; Sammy Saab
Journal:  Dig Dis Sci       Date:  2018-12-17       Impact factor: 3.199

2.  Race, Age, and Geography Impact Hepatitis C Genotype Distribution in the United States.

Authors:  Stuart C Gordon; Sheri Trudeau; Jia Li; Yueren Zhou; Loralee B Rupp; Scott D Holmberg; Anne C Moorman; Philip R Spradling; Eyasu H Teshale; Joseph A Boscarino; Yihe G Daida; Mark A Schmidt; Mei Lu
Journal:  J Clin Gastroenterol       Date:  2019-01       Impact factor: 3.062

Review 3.  Transplant for the very sick: No limitations in donor quality?

Authors:  Jennifer C Lai
Journal:  Liver Transpl       Date:  2017-10       Impact factor: 5.799

4.  The impact of diet-induced hepatic steatosis in a murine model of hepatic ischemia/reperfusion injury.

Authors:  Kim H H Liss; Kyle S McCommis; Kari T Chambers; Terri A Pietka; George G Schweitzer; Sara L Park; Ilke Nalbantoglu; Carla J Weinheimer; Angela M Hall; Brian N Finck
Journal:  Liver Transpl       Date:  2018-07       Impact factor: 5.799

5.  The impact of major extended donor criteria on graft failure and patient mortality after liver transplantation.

Authors:  Vladimir J Lozanovski; Elias Khajeh; Hamidreza Fonouni; Jan Pfeiffenberger; Rebecca von Haken; Thorsten Brenner; Markus Mieth; Peter Schirmacher; Christoph W Michalski; Karl Heinz Weiss; Markus W Büchler; Arianeb Mehrabi
Journal:  Langenbecks Arch Surg       Date:  2018-08-15       Impact factor: 2.895

6.  The Impact of Ischemia/Reperfusion Injury on Liver Allografts from Deceased after Cardiac Death versus Deceased after Brain Death Donors.

Authors:  Jin Xu; Blayne Amir Sayed; Ana Maria Casas-Ferreira; Parthi Srinivasan; Nigel Heaton; Mohammed Rela; Yun Ma; Susan Fuggle; Cristina Legido-Quigley; Wayel Jassem
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

7.  Elevated Preoperative Serum Bilirubin Improves Reperfusion Injury and Survival Postliver Transplantation.

Authors:  Vinzent Spetzler; Nicolas Goldaracena; Johann Moritz Kaths; Max Marquez; Markus Selzner; Nazia Selzner
Journal:  Transplant Direct       Date:  2017-07-05

8.  NKT cells are important mediators of hepatic ischemia-reperfusion injury.

Authors:  James A Richards; Stephen J Wigmore; Stephen M Anderton; Sarah E M Howie
Journal:  Transpl Immunol       Date:  2017-08-07       Impact factor: 1.708

Review 9.  The Potential Role of Liver Transplantation as a Treatment Option in Colorectal Liver Metastases.

Authors:  Pål-Dag Line; Morten Hagness; Svein Dueland
Journal:  Can J Gastroenterol Hepatol       Date:  2018-01-17

10.  Monoacylglycerol Acyltransferase 1 Knockdown Exacerbates Hepatic Ischemia/Reperfusion Injury in Mice With Hepatic Steatosis.

Authors:  Kim H H Liss; Shelby E Ek; Andrew J Lutkewitte; Terri A Pietka; Mai He; Priya Skaria; Eric Tycksen; Daniel Ferguson; Valerie Blanc; Mark J Graham; Angela M Hall; Mitchell R McGill; Kyle S McCommis; Brian N Finck
Journal:  Liver Transpl       Date:  2020-10-22       Impact factor: 5.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.